NYSE · Healthcare · Holders
AbbVie Inc. (ABBV) Institutional Ownership & Insider Trading History
Top ABBV institutional shareholders, filing changes, and Form 4 insider activity with filters for buys, sales, option exercises, gifts, and tax withholding.
- Last confirmed price
- $285.64+0.16%
- Oct 23, 2026, 4:01 PM EDT · Prices may be delayed
Data dates
Prices as of Oct 23, 4:01 PM EDT · Fundamentals checked Oct 24, 9:06 PM EDT · Statement period ended Jun 30, 2026
Ownership read
ABBV insider transaction activity: Net selling.
Blackrock Inc. is the largest institutional holder. 15 classified sales and 0 classified purchases appear in the recent insider records. Use the filters below to separate open-market activity from option exercises, gifts, awards, and tax withholding.
Insider flow
ABBV
Directional bars ignore awards, gifts, conversions, and tax withholding rows.
Top holder
149.49M
Blackrock Inc.
Insider transaction activity
Net selling
$88.01M sold / $0.0000 bought
Observations shown
77
10 holder / 67 insider
- Increased / initiated
- Unavailable
- Prior positions were not supplied
- Insider rows
- 67
- Transaction dates shown per row
Ownership concentration and transaction activity
- Top 10 reported holders
- 34.32% outstanding
- Changes with share-count history
- Prior-position data unavailable
- New / exited positions
- Prior-position data unavailable
- Largest increase with share-count history
- Prior share counts unavailable
These changes cover the holders shown. A holder missing from this list may still own shares. Compare positions from the same reporting quarters.
Net shares sold: 415,347
Sale-code S shares minus purchase-code P shares in this sample. Includes disclosed plans and unknown plan status; excludes grants, gifts, exercises and withholding. This is activity, not sentiment.
- Purchase / sale; plan unknown: 15
- Conversion / exercise: 8
- Grant: 43
- Gift: 1
Top 10 institutional holders
AbbVie Inc. (ABBV) institutional ownership
Ranked by reported share count, with position changes and separate position and filing dates where ownership data supplies them.
| # | Institution | % held | Shares | Position / filing date |
|---|---|---|---|---|
| 1 | 8.46% | 149.49M | Position as of Jun 30, 2026Filing date unknown | |
| 2 | 6.53% | 115.40M | Position as of Jun 30, 2026Filing date unknown | |
| 3 | 4.67% | 82.60M | Position as of Jun 30, 2026Filing date unknown | |
| 4 | 2.74% | 48.48M | Position as of Jun 30, 2026Filing date unknown | |
| 5 | 2.71% | 47.86M | Position as of Jun 30, 2026Filing date unknown | |
| 6 | 2.66% | 47.00M | Position as of Jun 30, 2026Filing date unknown | |
| 7 | 2.20% | 38.90M | Position as of Jun 30, 2026Filing date unknown | |
| 8 | 1.70% | 30.10M | Position as of Jun 30, 2026Filing date unknown | |
| 9 | 1.45% | 25.55M | Position as of Jun 30, 2026Filing date unknown | |
| 10 | 1.20% | 21.24M | Position as of Jun 30, 2026Filing date unknown |
Recent insider transactions
AbbVie Inc. (ABBV) Form 4 filings
Action codes are translated so open-market buys and sales are separate from awards, gifts, conversions, and tax withholding. Window: Dec 16, 2024–Aug 14, 2026 · 67 records.
| # | Insider | % company | Action | Shares | Price | Value | Transaction / filing |
|---|---|---|---|---|---|---|---|
| 1 | DONOGHOE NICHOLAS Officer | <0.01% | SaleOpen-market or direct sale reported on Form 4.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 32.71K | $250.00 | $8,177,500 | Aug 14, 2026Filing date unavailableOriginal filing link unavailable |
| 2 | DONOGHOE NICHOLAS Officer | <0.01% | ConversionConversion or exercise of derivative securities. Read alongside sale rows before treating it as bearish.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 32.71K | $79.02 | $2,584,744 | Aug 14, 2026Filing date unavailableOriginal filing link unavailable |
| 3 | MEYER MELODY B Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 4 | RAPP EDWARD J Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 5 | HART BRETT J Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 6 | BURNSIDE WILLIAM H L Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 7 | AUSTIN ROXANNE SCHUH Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 8 | WADDELL FREDERICK H Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 9 | FREYMAN THOMAS C Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 10 | FALK THOMAS J Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 11 | ROBERTS REBECCA B. Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
| 12 | DAVIS JENNIFER L Director | <0.01% | Award / grantAward, grant, or acquisition under an equity compensation plan.Transaction context
Position sold = shares sold ÷ (shares sold + holdings after). Separate accounts or security classes may not represent total beneficial ownership. | 1.12K | No cash value | No cash value | May 8, 2026Filing date unavailableOriginal filing link unavailable |
Frequently asked
Questions about this quote
Who are the largest ABBV shareholders?
Blackrock Inc. is the largest reported institutional holder of ABBV, with 149.49 million shares, or about 8.46% of shares outstanding.
What does the institutional filing activity show for ABBV?
AbbVie Inc. has 10 institutional rows on file. Previous position sizes are unavailable, so increases and reductions cannot be determined.
What insider transactions are available for ABBV?
TECHi shows 67 dated ABBV insider transactions through Aug 14, 2026, with transaction types kept separate so administrative actions are not presented as open-market trades.
Are ABBV insiders buying or selling?
The displayed ABBV activity reads Net selling: 15 sales and 0 purchases. Other transaction types remain separate.
Who is the most active reported ABBV insider?
GONZALEZ RICHARD A has the largest absolute share movement in the displayed ABBV filing rows, totaling 272,915 shares. The action labels provide the transaction context.
What this page answers
Check who owns the float and whether insiders are active.
Explore Institutional concentration, insider transaction pattern, and float context.
Keep in mind Filings are delayed or transactions are administrative rather than economic.
Market closed
Regular hours: 9:30 AM–4:00 PM America/New_York
Next open: 2026-10-26 · 9:30 AM America/New_York
Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.
Shortcuts
With research tools focused: / search · W watchlist · C compare · F financials · E earnings · N news · T technicals · Esc close